Antiva Bio is a healthcare startup that focuses on the development of innovative topical treatments for pre-cancerous cervical lesions and the Human Papillomavirus (HPV) infections that cause these lesions. The company's primary market is women who are diagnosed with HPV infections and pre-cancerous cervical lesions.

Currently, there is no treatment for HPV infection, and women are often left in a state of uncertainty, waiting to see if their infection clears up on its own or progresses to a more severe disease. Antiva Bio aims to change this by developing a first-of-its-kind therapy that women can use to treat themselves at home as soon as their infection is diagnosed.

This therapy also offers a non-surgical alternative for women whose disease has progressed further. This means that Antiva Bio's business model is centered around providing a simple, convenient, and non-invasive solution to a global health issue.

The company generates revenue by developing and selling these novel therapies. Their experienced team is committed to improving health outcomes and access to care worldwide, aligning with the World Health Organization’s global Cervical Cancer Elimination Initiative.

In summary, Antiva Bio is a pioneering healthcare startup that is developing innovative, home-based, non-surgical treatments for HPV infections and pre-cancerous cervical lesions, with a mission to improve women's health outcomes globally.

Keywords: Healthcare, Startup, HPV Infections, Pre-cancerous Cervical Lesions, Home-based Treatment, Non-surgical Treatment, Women's Health, Novel Therapies, Global Health, Cervical Cancer Elimination.